Palliation of Dyspnea in Advanced COPD: Understanding patient and caregiver experiences with opioid therapy.

晚期慢性阻塞性肺病患者呼吸困难的缓解：了解患者和护理人员使用阿片类药物治疗的经历。

• 批准号: 183318
• 负责人: Rocker Graeme M
• 金额: $ 7.29万
• 依托单位: Queen Elizabeth II Health Sciences Centre (Nova Scotia)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2008
• 资助国家: 加拿大
• 起止时间: 2008-09-01 至 2009-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=183318&lang=en
• 关键词: Advanced Copd; Palliation/End Of Life Care; Quality Of Life; Symptom Relief

Chronic Obstructive Pulmonary Disease (COPD) affects at least 750,000 Canadians and is currently the 4th leading cause of death in Canada. Almost everyone with COPD suffers from shortness of breath (dyspnea) that worsens over time despite standard treatme

慢性阻塞性肺疾病（COPD）影响至少75万加拿大人，目前是加拿大第四大死亡原因。几乎所有COPD患者都患有呼吸短促（呼吸困难），尽管进行了标准治疗，但随着时间的推移，